815 related articles for article (PubMed ID: 10421536)
1. Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels.
Abrams RA; Grochow LB; Chakravarthy A; Sohn TA; Zahurak ML; Haulk TL; Ord S; Hruban RH; Lillemoe KD; Pitt HA; Cameron JL; Yeo CJ
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1039-46. PubMed ID: 10421536
[TBL] [Abstract][Full Text] [Related]
2. Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
Chakravarthy A; Abrams RA; Yeo CJ; Korman LT; Donehower RC; Hruban RH; Zahurek ML; Grochow LB; O'Reilly S; Hurwitz H; Jaffee EM; Lillemoe KD; Cameron JL
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1089-96. PubMed ID: 11072167
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
[TBL] [Abstract][Full Text] [Related]
4. Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma.
Furuse J; Kinoshita T; Kawashima M; Ishii H; Nagase M; Konishi M; Nakagohri T; Inoue K; Ogino T; Ikeda H; Maru Y; Yoshino M
Cancer; 2003 Mar; 97(5):1346-52. PubMed ID: 12599244
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of tumour location after adjuvant chemoradiotherapy for periampullary adenocarcinoma.
Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Clin Transl Oncol; 2012 May; 14(5):391-5. PubMed ID: 22551547
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemoradiotherapy for "unfavorable" carcinoma of the ampulla of Vater: preliminary report.
Mehta VK; Fisher GA; Ford JM; Poen JC; Vierra MA; Oberhelman HA; Bastidas AJ
Arch Surg; 2001 Jan; 136(1):65-9. PubMed ID: 11146780
[TBL] [Abstract][Full Text] [Related]
7. The impact of resection margin status and postoperative CA19-9 levels on survival and patterns of recurrence after postoperative high-dose radiotherapy with 5-FU-based concurrent chemotherapy for resectable pancreatic cancer.
Kinsella TJ; Seo Y; Willis J; Stellato TA; Siegel CT; Harpp D; Willson JK; Gibbons J; Sanabria JR; Hardacre JM; Schulak JP
Am J Clin Oncol; 2008 Oct; 31(5):446-53. PubMed ID: 18838880
[TBL] [Abstract][Full Text] [Related]
8. Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer.
Movsas B; Hanlon AL; Lanciano R; Scher RM; Weiner LM; Sigurdson ER; Hoffman JP; Eisenberg BL; Cooper HS; Provins S; Coia LR
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):43-50. PubMed ID: 9747818
[TBL] [Abstract][Full Text] [Related]
9. Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study.
Al-Sukhun S; Zalupski MM; Ben-Josef E; Vaitkevicius VK; Philip PA; Soulen R; Weaver D; Adsay V; Heilbrun LK; Levin K; Forman JD; Shields AF
Am J Clin Oncol; 2003 Dec; 26(6):543-9. PubMed ID: 14663369
[TBL] [Abstract][Full Text] [Related]
10. Radiation dose ≥54 Gy and CA 19-9 response are associated with improved survival for unresectable, non-metastatic pancreatic cancer treated with chemoradiation.
Golden DW; Novak CJ; Minsky BD; Liauw SL
Radiat Oncol; 2012 Sep; 7():156. PubMed ID: 22974515
[TBL] [Abstract][Full Text] [Related]
11. Results and patterns of failure in patients treated with adjuvant combined chemoradiation therapy for resected pancreatic adenocarcinoma.
Hattangadi JA; Hong TS; Yeap BY; Mamon HJ
Cancer; 2009 Aug; 115(16):3640-50. PubMed ID: 19514088
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma.
Keene KS; Rich TA; Penberthy DR; Shepard RC; Adams R; Jones RS
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):97-103. PubMed ID: 15850908
[TBL] [Abstract][Full Text] [Related]
13. Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.
O'Connor JK; Sause WT; Hazard LJ; Belnap LP; Noyes RD
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1060-6. PubMed ID: 15978737
[TBL] [Abstract][Full Text] [Related]
14. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.
Yeo CJ; Abrams RA; Grochow LB; Sohn TA; Ord SE; Hruban RH; Zahurak ML; Dooley WC; Coleman J; Sauter PK; Pitt HA; Lillemoe KD; Cameron JL
Ann Surg; 1997 May; 225(5):621-33; discussion 633-6. PubMed ID: 9193189
[TBL] [Abstract][Full Text] [Related]
15. Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial.
Neoptolemos JP; Moore MJ; Cox TF; Valle JW; Palmer DH; McDonald AC; Carter R; Tebbutt NC; Dervenis C; Smith D; Glimelius B; Charnley RM; Lacaine F; Scarfe AG; Middleton MR; Anthoney A; Ghaneh P; Halloran CM; Lerch MM; Oláh A; Rawcliffe CL; Verbeke CS; Campbell F; Büchler MW;
JAMA; 2012 Jul; 308(2):147-56. PubMed ID: 22782416
[TBL] [Abstract][Full Text] [Related]
16. Effect of Pancreatic Fistula on Recurrence and Long-Term Prognosis of Periampullary Adenocarcinomas after Pancreaticoduodenectomy.
Serrano PE; Kim D; Kim PT; Greig PD; Moulton CA; Gallinger S; Wei AC; Cleary SP
Am Surg; 2016 Dec; 82(12):1187-1195. PubMed ID: 28234183
[TBL] [Abstract][Full Text] [Related]
17. Role of adjuvant chemoradiotherapy for ampulla of Vater cancer.
Kim K; Chie EK; Jang JY; Kim SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):436-41. PubMed ID: 19394162
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study.
Narang AK; Miller RC; Hsu CC; Bhatia S; Pawlik TM; Laheru D; Hruban RH; Zhou J; Winter JM; Haddock MG; Donohue JH; Schulick RD; Wolfgang CL; Cameron JL; Herman JM
Radiat Oncol; 2011 Sep; 6():126. PubMed ID: 21951377
[TBL] [Abstract][Full Text] [Related]
19. Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomy.
Carducci MA; Abrams RA; Yeo CJ; Hruban RH; Zahurak ML; Cameron JL; Grochow LB
Int J Radiat Oncol Biol Phys; 1996 Apr; 35(1):143-50. PubMed ID: 8641911
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group.
Klinkenbijl JH; Jeekel J; Sahmoud T; van Pel R; Couvreur ML; Veenhof CH; Arnaud JP; Gonzalez DG; de Wit LT; Hennipman A; Wils J
Ann Surg; 1999 Dec; 230(6):776-82; discussion 782-4. PubMed ID: 10615932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
